A detailed history of Principal Securities, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 38 shares of BBIO stock, worth $1,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38
Previous 141 73.05%
Holding current value
$1,084
Previous $3.57 Million 72.93%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$23.91 - $31.3 $2,462 - $3,223
-103 Reduced 73.05%
38 $967,000
Q1 2024

May 10, 2024

SELL
$27.35 - $40.45 $2,461 - $3,640
-90 Reduced 38.96%
141 $4.36 Million
Q4 2023

Feb 07, 2024

BUY
$24.02 - $43.89 $5,548 - $10,138
231 New
231 $9.33 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.